Trial Profile
Efficacy and safety of trough level-based dose reduction during infliximab maintenance treatment in Crohn's disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2014
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms REDIX
- 08 Jul 2014 New trial record